Krystal Biotech (KRYS) Stock Price
$187.9 0%
to add to portfolio
AI Score

-
Alternative
6 -
Fundamental
8 -
Technical
6
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Krystal Biotech, AI stock picks, stock alerts and much more.
KRYS AI Stock Analysis
AI stock analysis for KRYS is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Krystal Biotech (KRYS) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Krystal Biotech (KRYS) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Krystal Biotech (KRYS), currently trading at $187.9, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About KRYS

-
Krystal Biotech, Inc.
-
Symbol
KRYS
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
5.4B
Similar Stocks
![]() |
Catalyst Pharmaceuticals CPRX |
$21.62 2% |
6 |
![]() |
Inovio Pharmaceuticals INO |
$2.24 0.9% |
2 |
![]() |
Moderna MRNA |
$35.53 5.3% |
4 |
![]() |
Anavex Life Sciences AVXL |
$8.35 3.8% |
6 |
![]() |
BridgeBio Pharma BBIO |
$36.85 0.1% |
6 |
News
KRYS Alternative Data
Web Traffic
Krystal Biotech receives an estimated 10387 monthly visitors to krystalbio.com.
-
Web Traffic
10387
-
Change from Previous Month
4.2%
-
3 Month Change
36.1%
-
YoY Change
36.1%
News Mentions
Krystal Biotech was mentioned 1 times in the news yesterday.
-
News Mentions
1
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Reddit Mentions
Krystal Biotech has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
Twitter Followers
Krystal Biotech has 1,054 Twitter Followers on its main Twitter (also known as X) account, which is down by -0.1% over the last month.
-
Twitter Followers
1054
-
Daily Change
0.1%
-
1 Month Change
0.1%
-
3 Month Change
2.4%
LinkedIn Followers
24,037 are following Krystal Biotech on LinkedIn, up by 2.4% over the last month.
-
LinkedIn Followers
24037
-
Daily Change
0%
-
1 Month Change
2.4%
-
3 Month Change
4.6%
Job Postings
Krystal Biotech currenly has an estimated 14 open job postings, up by 7.7% over the last month.
-
Job Postings
14
-
Daily Change
7.7%
-
1 Month Change
7.7%
-
3 Month Change
26.3%
LinkedIn Employees
According to LinkedIn, Krystal Biotech has 277 employees, up by 1.1% over the last month.
-
LinkedIn Employees
277
-
Daily Change
0%
-
1 Month Change
1.1%
-
3 Month Change
4.9%
Business Outlook
-
Business Outlook
41
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
KRYS Financials
KRYS Key Metrics
-
Total Revenue
$83.8M
-
Net Income
$27.2M
-
Earnings per Share
$0.95
-
Free cash flow
$57.8M
-
EBITDA
$22.4M
-
EBITDA Ratio
0.267566
-
Total Assets
$982.3M
KRYS 2-year Revenue & Income
KRYS 2-year Free Cash Flow
KRYS Technicals
KRYS SMA
KRYS RSI
FAQ
What's the current price of Krystal Biotech (KRYS) Stock?
The price of an Krystal Biotech (KRYS) share is $187.9.
What's the market cap of Krystal Biotech?
The current market cap of Krystal Biotech is 5.4B.
Should I buy or sell KRYS?
Multiple alternative data signals suggest that Krystal Biotech stock could offer a buying opportunity at its current level, with a reasonable expectation for positive performance in the mid term.
Is Krystal Biotech a good investment?
Based on an in-depth analysis that encompasses fundamentals, technical analysis, and alternative data insights, it appears to be a favorable time to consider investing in Krystal Biotech stock. The bullish indicators suggest that Krystal Biotech's growth prospects and market position may lead to a positive performance in the foreseeable future.
Is now a good time to buy Krystal Biotech (KRYS) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it could be a favorable time to consider buying Krystal Biotech stock, given the bullish outlook.
What are some stocks similar to Krystal Biotech (KRYS) that investors often compare it to?
Krystal Biotech (KRYS) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for Krystal Biotech's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Krystal Biotech's stock price to be around $201.6 in 2026. Starting from the current price of $187.9, this represents a 7.3% change in price, indicating a bullish outlook for the stock.
How to buy Krystal Biotech (KRYS) Stock?
Krystal Biotech stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Krystal Biotech shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.